Qube Research & Technologies (QRT)’s Armata Pharmaceuticals ARMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273K Buy
26,628
+3,272
+14% +$27.5K ﹤0.01% 2887
2025
Q4
$147K Buy
+23,356
New +$128K ﹤0.01% 3121
2024
Q3
Sell
-1,908
Closed -$5.25K 3284
2024
Q2
$5.25K Sell
1,908
-20,506
-91% -$58.5K ﹤0.01% 3035
2024
Q1
$93.7K Sell
22,414
-1,149
-5% -$4.16K ﹤0.01% 3324
2023
Q4
$76.3K Buy
23,563
+21,372
+975% +$50.5K ﹤0.01% 3184
2023
Q3
$6.57K Buy
+2,191
New +$5.88K ﹤0.01% 3400

Other funds holding ARMP

Qube Research & Technologies (QRT)'s ARMP Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Armata Pharmaceuticals (ARMP) stake by 14% in Q1 2026, buying an estimated $27.5K and bringing the position to 26,628 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #2887.

Qube Research & Technologies (QRT) first reported a position in ARMP in Q3 2023 and has held it in 6 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Qube Research & Technologies (QRT) held 26,628 shares of Armata Pharmaceuticals worth $273K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 3,272 Armata Pharmaceuticals shares in Q1 2026, an estimated $27.5K.
  • Armata Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2887 holding.
  • Qube Research & Technologies (QRT) first reported a position in Armata Pharmaceuticals in Q3 2023 and has held it in 6 quarters since.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.